Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - LA JOLLA PHARMACEUTICAL CO | Financial_Report.xls |
| 10-K - FORM 10-K - LA JOLLA PHARMACEUTICAL CO | d286951d10k.htm |
| EX-21.1 - EX-21.1 - LA JOLLA PHARMACEUTICAL CO | d286951dex211.htm |
| EX-31.1 - EX-31.1 - LA JOLLA PHARMACEUTICAL CO | d286951dex311.htm |
| EX-32.1 - EX-32.1 - LA JOLLA PHARMACEUTICAL CO | d286951dex321.htm |
| EX-10.6 - EX-10.6 - LA JOLLA PHARMACEUTICAL CO | d286951dex106.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
La Jolla Pharmaceutical Company
San Diego, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 Nos. 333-106060, 333-116233, 333-125427, 333-131248, 333-143677, 333-151825 and 333-169140 of La Jolla Pharmaceutical Company of our report dated March 30, 2012, relating to the consolidated financial statements, which appear in the Annual Report on Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
| /s/ BDO USA, LLP |
| San Diego, California |